Objective: Chronic thromboembolic pulmonary hypertension (CTEPH) has poor prognosis.
Results: Patients underwent BPA repeatedly (2.4 (range, 1 to 6) procedures and 6.8 (range, 4 to 22) dilatations). None of the patients died because of BPA. All patients developed reperfusion pulmonary edema after BPA and mechanical ventilation was required in 3 patients. Pulmonary artery perforation occurred in 4 patients and emergency transcatheter embolization with coils prevented fatal bleeding. The averaged WHO functional class improved from 3.3 to 2.1 (P=0.011) and BNP levels decreased from 312.6±271.2 to 47.5±77.6 pg/ml (P<0.001). 6MWD improved from 191 to 292 m (P<0.005). Systolic and mean PAP significantly decreased after BPA (from 88.1±15.9 to 50.2±11.9 and from 49.2±8.9 to 28.8±7.1 mmHg (P<0.001), respectively). Twenty out of 48 patients have been followed up for more than one year after initial BPA. All of them are alive and 10 patients underwent right heart catheterization at one year after initial BPA. In these patients, mean PAP was 25.3±3.7 mmHg after BPA and 26.1±5.7 mmHg at follow up (P>0.05). The improvement of hemodynamics was maintained over a year.
Conclusions: BPA could improve hemodynamics and clinical status of patients with peripheral type CTEPH who received full medication. BPA would be an effective therapeutic option in these patients who have otherwise no proven treatment.
